Loss of Cbl-PI3K Interaction in Mice Prevents Significant Bone Loss Following Ovariectomy

Overview

Journal Bone

Specialties Endocrinology
Orthopedics

Date 2014 Jul 5

PMID 24994594

Citations 6

Authors

Naga Suresh Adapala

Danielle Holland

Vanessa Scanlon

Mary F Barbe

Wallace Y Langdon

Alexander Y Tsygankov

Joseph A Lorenzo

Archana Sanjay

Affiliations

Soon will be listed here.

Abstract

Cbl and Cbl-b are E3 ubiquitin ligases and adaptor proteins, which perform regulatory roles in bone remodeling. Cbl-/- mice have delayed bone development due to decreased osteoclast migration. Cbl-b-/- mice are osteopenic due to increased bone resorbing activity of osteoclasts. Unique to Cbl, but not present in Cbl-b, is tyrosine 737 in the YEAM motif, which upon phosphorylation provides a binding site for the regulatory p85 subunit of PI3K. Substitution of tyrosine 737 with phenylalanine (Y737F, CblYF/YF mice) prevents Y737 phosphorylation and abrogates the Cbl-PI3K interaction. We have previously reported that CblYF/YF mice had increased bone volume due to defective bone resorption and increased bone formation. Here we show that the lumbar vertebra from CblYF/YF mice did not have significant bone loss following ovariectomy. Our data also suggests that abrogation of Cbl-PI3K interaction in mice results in the loss of coupling between bone resorption and formation, since ovariectomized CblYF/YF mice did not show significant changes in serum levels of c-terminal telopeptide (CTX), whereas the serum levels of pro-collagen type-1 amino-terminal pro-peptide (P1NP) were decreased. In contrast, following ovariectomy, Cbl-/- and Cbl-b-/- mice showed significant bone loss in the tibiae and L2 vertebrae, concomitant with increased serum CTX and P1NP levels. These data indicate that while lack of Cbl or Cbl-b distinctly affects bone remodeling, only the loss of Cbl-PI3K interaction protects mice from significant bone loss following ovariectomy.

Citing Articles

Wnt-associated adult stem cell marker Lgr6 is required for osteogenesis and fracture healing.

Doherty L, Wan M, Peterson A, Youngstrom D, King J, Kalajzic I Bone. 2023; 169:116681.

PMID: 36708855 PMC: 10015414. DOI: 10.1016/j.bone.2023.116681.

Cbl-PI3K interaction regulates Cathepsin K secretion in osteoclasts.

Yu J, Adapala N, Doherty L, Sanjay A Bone. 2019; 127:376-385.

PMID: 31299383 PMC: 6708784. DOI: 10.1016/j.bone.2019.07.009.

PI3K activation increases SDF-1 production and number of osteoclast precursors, and enhances SDF-1-mediated osteoclast precursor migration.

Adapala N, Root S, Lorenzo J, Aguila H, Sanjay A Bone Rep. 2019; 10:100203.

PMID: 30989092 PMC: 6449702. DOI: 10.1016/j.bonr.2019.100203.

Tectorigenin inhibits RANKL-induced osteoclastogenesis via suppression of NF-κB signalling and decreases bone loss in ovariectomized C57BL/6.

Ma C, Xu K, Meng J, Ran J, Adel Abdo Moqbel S, Liu A J Cell Mol Med. 2018; 22(10):5121-5131.

PMID: 30063119 PMC: 6156464. DOI: 10.1111/jcmm.13801.

Role of Cbl-PI3K Interaction during Skeletal Remodeling in a Murine Model of Bone Repair.

Scanlon V, Soung D, Adapala N, Morgan E, Hansen M, Drissi H PLoS One. 2015; 10(9):e0138194.

PMID: 26393915 PMC: 4578922. DOI: 10.1371/journal.pone.0138194.

References

Turner R . Mice, estrogen, and postmenopausal osteoporosis. J Bone Miner Res. 1999; 14(2):187-91. DOI: 10.1359/jbmr.1999.14.2.187. View

Wu Y, Torchia J, Yao W, Lane N, Lanier L, Nakamura M . Bone microenvironment specific roles of ITAM adapter signaling during bone remodeling induced by acute estrogen-deficiency. PLoS One. 2007; 2(7):e586. PMC: 1895921. DOI: 10.1371/journal.pone.0000586. View

Lotinun S, Kiviranta R, Matsubara T, Alzate J, Neff L, Luth A . Osteoclast-specific cathepsin K deletion stimulates S1P-dependent bone formation. J Clin Invest. 2013; 123(2):666-81. PMC: 3561821. DOI: 10.1172/JCI64840. View

Thien C, Langdon W . Cbl: many adaptations to regulate protein tyrosine kinases. Nat Rev Mol Cell Biol. 2001; 2(4):294-307. DOI: 10.1038/35067100. View

Thien C, Dagger S, Steer J, Koentgen F, Jansen E, Scott C . c-Cbl promotes T cell receptor-induced thymocyte apoptosis by activating the phosphatidylinositol 3-kinase/Akt pathway. J Biol Chem. 2010; 285(14):10969-81. PMC: 2856302. DOI: 10.1074/jbc.M109.094920. View

Molero J, Turner N, Thien C, Langdon W, James D, Cooney G . Genetic ablation of the c-Cbl ubiquitin ligase domain results in increased energy expenditure and improved insulin action. Diabetes. 2006; 55(12):3411-7. DOI: 10.2337/db06-0955. View

Adapala N, Barbe M, Tsygankov A, Lorenzo J, Sanjay A . Loss of Cbl-PI3K interaction enhances osteoclast survival due to p21-Ras mediated PI3K activation independent of Cbl-b. J Cell Biochem. 2014; 115(7):1277-89. PMC: 4634568. DOI: 10.1002/jcb.24779. View

Back S, Adapala N, Barbe M, Carpino N, Tsygankov A, Sanjay A . TULA-2, a novel histidine phosphatase, regulates bone remodeling by modulating osteoclast function. Cell Mol Life Sci. 2012; 70(7):1269-84. PMC: 3752794. DOI: 10.1007/s00018-012-1203-2. View

Thien C, Langdon W . c-Cbl and Cbl-b ubiquitin ligases: substrate diversity and the negative regulation of signalling responses. Biochem J. 2005; 391(Pt 2):153-66. PMC: 1276912. DOI: 10.1042/BJ20050892. View

10.

Horne W, Sanjay A, Bruzzaniti A, Baron R . The role(s) of Src kinase and Cbl proteins in the regulation of osteoclast differentiation and function. Immunol Rev. 2005; 208:106-25. DOI: 10.1111/j.0105-2896.2005.00335.x. View

11.

Chiusaroli R, Sanjay A, Henriksen K, Engsig M, Horne W, Gu H . Deletion of the gene encoding c-Cbl alters the ability of osteoclasts to migrate, delaying resorption and ossification of cartilage during the development of long bones. Dev Biol. 2003; 261(2):537-47. DOI: 10.1016/s0012-1606(03)00299-9. View

12.

Sanjay A, Houghton A, Neff L, DiDomenico E, Bardelay C, Antoine E . Cbl associates with Pyk2 and Src to regulate Src kinase activity, alpha(v)beta(3) integrin-mediated signaling, cell adhesion, and osteoclast motility. J Cell Biol. 2001; 152(1):181-95. PMC: 2193648. DOI: 10.1083/jcb.152.1.181. View

13.

Dufour C, Guenou H, Kaabeche K, Bouvard D, Sanjay A, Marie P . FGFR2-Cbl interaction in lipid rafts triggers attenuation of PI3K/Akt signaling and osteoblast survival. Bone. 2008; 42(6):1032-9. DOI: 10.1016/j.bone.2008.02.009. View

14.

Adapala N, Barbe M, Langdon W, Tsygankov A, Sanjay A . Cbl-phosphatidylinositol 3 kinase interaction differentially regulates macrophage colony-stimulating factor-mediated osteoclast survival and cytoskeletal reorganization. Ann N Y Acad Sci. 2010; 1192:376-84. DOI: 10.1111/j.1749-6632.2009.05346.x. View

15.

Hunter S, Burton E, Wu S, Anderson S . Fyn associates with Cbl and phosphorylates tyrosine 731 in Cbl, a binding site for phosphatidylinositol 3-kinase. J Biol Chem. 1999; 274(4):2097-106. DOI: 10.1074/jbc.274.4.2097. View

16.

Adapala N, Barbe M, Langdon W, Nakamura M, Tsygankov A, Sanjay A . The loss of Cbl-phosphatidylinositol 3-kinase interaction perturbs RANKL-mediated signaling, inhibiting bone resorption and promoting osteoclast survival. J Biol Chem. 2010; 285(47):36745-58. PMC: 2978603. DOI: 10.1074/jbc.M110.124628. View

17.

Weitzmann M, Pacifici R . Estrogen deficiency and bone loss: an inflammatory tale. J Clin Invest. 2006; 116(5):1186-94. PMC: 1451218. DOI: 10.1172/JCI28550. View

18.

Walker E, McGregor N, Poulton I, Pompolo S, Allan E, Quinn J . Cardiotrophin-1 is an osteoclast-derived stimulus of bone formation required for normal bone remodeling. J Bone Miner Res. 2008; 23(12):2025-32. DOI: 10.1359/jbmr.080706. View

19.

Pacifici R . Estrogen, cytokines, and pathogenesis of postmenopausal osteoporosis. J Bone Miner Res. 1996; 11(8):1043-51. DOI: 10.1002/jbmr.5650110802. View

20.

Nakajima A, Sanjay A, Chiusaroli R, Adapala N, Neff L, Itzsteink C . Loss of Cbl-b increases osteoclast bone-resorbing activity and induces osteopenia. J Bone Miner Res. 2009; 24(7):1162-72. PMC: 2697622. DOI: 10.1359/jbmr.090205. View